Showing results (1-10 of 49) with videos related to

Sort By:
Pageof 5
Advances in Biological Regulation|April 5, 2017
Cross-talk between the CK2 and AKT signaling pathways in cancerMaria Ruzzene, Jessika Bertacchini, Alex Toker, et al.
Biomedicines|June 9, 2018
Osteocytes Specific GSK3 Inhibition Affects In Vitro Osteogenic DifferentiationJessika Bertacchini, Maria Sara Magarò, Francesco Potì, et al.
Cellular Oncology (Dordrecht, Netherlands)|October 14, 2015
Inhibition of Ras-mediated signaling pathways in CML stem cellsJessika Bertacchini, Neda Ketabchi, Laura Mediani, et al.
Cell Journal|June 6, 2017
Significance of Inactivated Genes in Leukemia: Pathogenesis and PrognosisNazanin Heidari, Saeid Abroun, Jessika Bertacchini, et al.
International Journal of Hematology-Oncology and Stem Cell Research|February 12, 2016
The Role of HDACs as Leukemia Therapy Targets using HDIAhmad Ahmadzadeh, Elahe Khodadi, Mohammad Shahjahani, et al.
Biomedicines|June 17, 2017
Biocompatibility Analyses of Al₂O₃-Treated Titanium Plates Tested with Osteocyte and Fibroblast Cell LinesAlberto Smargiassi, Jessika Bertacchini, Marta Checchi, et al.
Cancers|July 2, 2021
Autoimmunity Profiles as Prognostic Indicators in Patients with Colorectal Cancer versus Those with Cancer at Other Sites: A Prospective StudyPaola Sena, Stefano Mancini, Jessika Bertacchini, et al.
Biochemical Genetics|February 2, 2018
Aberrant DNA Methylation in Chronic Myeloid Leukemia: Cell Fate Control, Prognosis, and Therapeutic ResponseMasumeh Maleki Behzad, Saeid Shahrabi, Kaveh Jaseb, et al.
Cellular and Molecular Life Sciences : CMLS|February 26, 2015
Targeting PI3K/AKT/mTOR network for treatment of leukemiaJessika Bertacchini, Nazanin Heidari, Laura Mediani, et al.
Cancers|May 14, 2025
Differential Cytotoxicity of Surface-Functionalized Silver Nanoparticles in Colorectal Cancer and Ex-Vivo Healthy Colonocyte ModelsMarianna Barbalinardo, Emilia Benvenuti, Denis Gentili, et al.
Pageof 5